Thalidomide - PDFSEARCH.IO - Document Search Engine

Thalidomide
Results: 198

#	Item
21	MEDICATION GUIDE REVLIMID® (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID? • Before you begin taking REVLIMID, you must read and agree to all of the Add to Reading List Source URL: assets1.celgene.com Language: English - Date: 2015-02-18 10:03:26 Health Lenalidomide Celgene Thalidomide B-cell chronic lymphocytic leukemia Pregnancy Myelodysplastic syndrome Medicine Immunosuppressants Oncology
22	Annual ReportMultiple Myeloma Research Foundation Mission Statement Add to Reading List Source URL: www.themmrf.org Language: English - Date: 2014-09-09 12:19:52 Cancer organizations Norwalk Connecticut Immunosuppressants Multiple Myeloma Research Foundation Multiple Myeloma Research Consortium Kathy Giusti Lenalidomide Bortezomib Thalidomide Medicine Oncology Cancer research
23	HIGHLIGHTS OF PRESCRIBING INFORMATION Add to Reading List Source URL: assets1.celgene.com Language: English - Date: 2014-06-26 16:25:49 Immunosuppressants Pharmacology Carcinogens Leprosy Phthalimides Thalidomide Multiple myeloma Dexamethasone Adverse effect Medicine Chemistry Organic chemistry
24	Microsoft Word - HAA abstracts Tuesday_tam.doc Add to Reading List Source URL: www.anzsbt.org.au Language: English - Date: 2008-05-06 23:33:17 Immunosuppressants Cell biology Apoptosis Lenalidomide Multiple myeloma Rare diseases Carfilzomib Thalidomide AKT Biology Chemistry Medicine
25	Microsoft Word - pomalidomide-psddocx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Medical statistics Lenalidomide Orphan drugs Multiple myeloma Bortezomib Dexamethasone Thalidomide End point of clinical trials Celgene Medicine Health Immunosuppressants
26	5.13 POMALIDOMIDE, capsules, 3 mg and 4 mg, Pomalyst®, Celgene Pty Ltd. Purpose of Application Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Medical statistics Lenalidomide Multiple myeloma Bortezomib Dexamethasone End point of clinical trials Thalidomide Celgene Clinical trial Medicine Health Immunosuppressants
27	Essays of an Information Scientist, Vol:9, p.404, 1986 Current Contents, #50, p3-11, December 15, 1986 =urrsnt Eommsnts” EUGENE GARFIELD INSTITUTE Add to Reading List Source URL: www.garfield.library.upenn.edu Language: English - Date: 1999-10-01 16:28:23 Pharmacology Teratogens Developmental biology Carcinogens Immunosuppressants Thalidomide Teratology James G. Wilson Phocomelia Medicine Health Biology
28	Serial Claims-When one event leads to many lawsuits. Issues for Indemnifiers with examples from the past, present and future Dr Sharmala Moodley Add to Reading List Source URL: www.piaa2014.com Language: English - Date: 2014-10-03 03:31:34 Thalidomide Negligence Norplant Chemistry Health Medicine Tort law Product liability
29	National Chemotherapy Algorithms MULTIPLE MYELOMA SEE MYELOMA – TRANSPLANT ELIGIBLE Add to Reading List Source URL: www.engage.england.nhs.uk Language: English - Date: 2015-03-23 13:59:26 Lenalidomide Bortezomib Dexamethasone Thalidomide Chemotherapy Plasma cell leukemia International Myeloma Working Group Medicine Immunosuppressants Multiple myeloma
30	O u rs elves U n bo r n : Emb ryology C o l lo q u i u m The Women’s College, University of Sydney Wednesday 17 th September 2014 Three prominent Women’s College Alumnae discuss their ground breaking research into bi Add to Reading List Source URL: www.thewomenscollege.com.au Language: English - Date: 2014-08-15 16:17:20 Thalidomide Chemistry Health Medicine Association of Commonwealth Universities University of Sydney

UPDATE